JP2013525285A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013525285A5 JP2013525285A5 JP2013503991A JP2013503991A JP2013525285A5 JP 2013525285 A5 JP2013525285 A5 JP 2013525285A5 JP 2013503991 A JP2013503991 A JP 2013503991A JP 2013503991 A JP2013503991 A JP 2013503991A JP 2013525285 A5 JP2013525285 A5 JP 2013525285A5
- Authority
- JP
- Japan
- Prior art keywords
- molecules
- composition
- membrane
- homing
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32220710P | 2010-04-08 | 2010-04-08 | |
| US61/322,207 | 2010-04-08 | ||
| US37685610P | 2010-08-25 | 2010-08-25 | |
| US61/376,856 | 2010-08-25 | ||
| PCT/US2011/031785 WO2011127405A1 (en) | 2010-04-08 | 2011-04-08 | Methods and compositions for enhanced delivery of compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013525285A JP2013525285A (ja) | 2013-06-20 |
| JP2013525285A5 true JP2013525285A5 (cg-RX-API-DMAC10.html) | 2014-05-15 |
Family
ID=44120964
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013503991A Pending JP2013525285A (ja) | 2010-04-08 | 2011-04-08 | 化合物の送達を増強するための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20110262347A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2555802A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2013525285A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2795289A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2011127405A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10363309B2 (en) * | 2011-02-04 | 2019-07-30 | Case Western Reserve University | Targeted nanoparticle conjugates |
| WO2012135550A1 (en) * | 2011-03-30 | 2012-10-04 | Luna Innovations Incorporated | Biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaque |
| US20130116404A1 (en) | 2011-11-08 | 2013-05-09 | Case Western Reserve University | Targeted non-invasive imaging probes of egfr expressing cells |
| US20130195752A1 (en) | 2012-02-01 | 2013-08-01 | Regents Of The University Of Minnesota | Functionalized nanoparticles and methods of use thereof |
| US20130217765A1 (en) * | 2012-02-16 | 2013-08-22 | Eric Brown | Multifunctional nanoconjugates and uses thereof |
| EP2671597A1 (en) * | 2012-06-07 | 2013-12-11 | Cepep III AB | Chimeric constructs between glioma-homing peptide and cell-penetrating peptides, gHoPe2 |
| CA2919268C (en) | 2013-07-25 | 2023-09-05 | Exicure, Inc. | Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use |
| AU2015269412B2 (en) | 2014-06-04 | 2020-03-12 | Exicure Operating Company | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications |
| CN106794217A (zh) * | 2014-08-06 | 2017-05-31 | 血管生物科学 | 包含对患病组织具有选择性的药效团的组合物及其制备方法 |
| EP3183007B1 (en) * | 2014-08-19 | 2020-06-17 | Northwestern University | Protein/oligonucleotide core-shell nanoparticle therapeutics |
| BR112017007012A2 (pt) | 2014-10-06 | 2018-03-06 | Exicure Inc | compostos anti-tnf |
| EP3017809A1 (en) * | 2014-11-07 | 2016-05-11 | Ferring B.V. | Drug-device unit containing quinagolide |
| WO2016081911A2 (en) | 2014-11-21 | 2016-05-26 | Northwestern University | The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates |
| WO2016172515A1 (en) | 2015-04-23 | 2016-10-27 | Sanford Burnham Prebys Medical Discovery Institute | Targeted delivery system and methods of use therefor |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| CN105055315B (zh) * | 2015-08-03 | 2017-10-31 | 四川大学 | 一种交联线粒体靶向阿霉素脂质体及其制备方法 |
| CN106220735A (zh) * | 2015-09-11 | 2016-12-14 | 中山大学 | 一种组织蛋白酶b激活式靶向抗肿瘤多肽的制备与应用 |
| CN105395483B (zh) * | 2015-12-21 | 2018-09-28 | 江南大学 | 一种可还原降解超支化聚合物纳米胶束及其制备方法 |
| WO2018039629A2 (en) | 2016-08-25 | 2018-03-01 | Northwestern University | Micellar spherical nucleic acids from thermoresponsive, traceless templates |
| WO2018085050A1 (en) | 2016-11-03 | 2018-05-11 | Sanford Burnham Prebys Medical Discovery Institute | Compositions and methods for imaging tissues and tumors |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| AU2017384425B2 (en) | 2016-12-21 | 2023-08-31 | Nanobiotix | Nanoparticles for use for treating a neuronal disorder |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| CN111712468A (zh) | 2017-12-22 | 2020-09-25 | 北卡罗莱纳州立大学 | 聚合物荧光团、包含其的组合物及制备和使用其的方法 |
| WO2019183633A1 (en) | 2018-03-23 | 2019-09-26 | Case Western Reserve Univeristy | Psma targeted conjugate compounds and uses thereof |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| WO2020190556A1 (en) * | 2019-03-18 | 2020-09-24 | Novomer, Inc. | Membrane separation system, and uses thereof |
| WO2021242917A1 (en) * | 2020-05-27 | 2021-12-02 | Georgetown University | Targeting the cholecystokinin-b receptor for imaging and early detection of pancreatic cancer and pre-cancerous lesions |
| US20250332265A1 (en) | 2021-11-09 | 2025-10-30 | Case Western Reserve University | Psma targeted conjugate compounds and uses thereof |
| CN114106108B (zh) * | 2021-11-25 | 2023-07-14 | 中国石油大学(华东) | 一种多肽-金纳米颗粒复合物、其制备方法及应用 |
| CN114732796B (zh) * | 2022-02-18 | 2023-01-17 | 北京大学第三医院(北京大学第三临床医学院) | 一种双靶向载药微泡及其制备方法和应用 |
| WO2025186514A1 (en) * | 2024-03-07 | 2025-09-12 | University Of Helsinki | Cancer cell targeting peptide |
| WO2026150165A1 (en) * | 2025-01-09 | 2026-07-16 | Tampere University Foundation Sr | Tissue-penetrating homing peptides, peptide conjugates and compositions comprising the same |
Family Cites Families (59)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1016978B (de) | 1955-05-16 | 1957-10-03 | Iashellia Res Ltd | Mittel zur Bekaempfung des Pflanzenwachstums |
| FR1601438A (cg-RX-API-DMAC10.html) | 1968-10-17 | 1970-08-24 | ||
| CH588887A5 (cg-RX-API-DMAC10.html) | 1974-07-19 | 1977-06-15 | Battelle Memorial Institute | |
| JPS5186117A (en) | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| NO812612L (no) | 1980-08-06 | 1982-02-08 | Ferring Pharma Ltd | Enzym-inhibitorer. |
| US4418052A (en) | 1980-08-12 | 1983-11-29 | Wong Dennis W | Diagnostic compositions and method for radiologic imaging of fibrinogen deposition in the body |
| US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
| GB8416234D0 (en) | 1984-06-26 | 1984-08-01 | Ici Plc | Biodegradable amphipathic copolymers |
| US4761288A (en) | 1984-09-24 | 1988-08-02 | Mezei Associates Limited | Multiphase liposomal drug delivery system |
| US5628936A (en) | 1987-03-13 | 1997-05-13 | Micro-Pak, Inc. | Hybrid paucilamellar lipid vesicles |
| US5474848A (en) | 1987-03-13 | 1995-12-12 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US4853228A (en) | 1987-07-28 | 1989-08-01 | Micro-Pak, Inc. | Method of manufacturing unilamellar lipid vesicles |
| US5011686A (en) | 1987-09-21 | 1991-04-30 | Creative Biomolecules, Inc. | Thrombus specific conjugates |
| US5013497A (en) | 1988-03-03 | 1991-05-07 | Micro-Pak, Inc. | Method and apparatus for producing lipid vesicles |
| US5024829A (en) | 1988-11-21 | 1991-06-18 | Centocor, Inc. | Method of imaging coronary thrombi |
| JP2517760B2 (ja) | 1989-05-11 | 1996-07-24 | 新技術事業団 | 水溶性高分子化医薬製剤 |
| US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| US5792742A (en) | 1991-06-14 | 1998-08-11 | New York University | Fibrin-binding peptide fragments of fibronectin |
| FR2735658B1 (fr) | 1995-06-21 | 1997-09-12 | Capsulis | Encapsulation de composes a usage alimentaire par des tensioactifs |
| KR940003548U (ko) | 1992-08-14 | 1994-02-21 | 김형술 | 세탁물 건조기 |
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| CA2163860A1 (en) | 1993-06-30 | 1995-01-12 | Chung C. Hsu | Method for preparing liposomes |
| US5536814A (en) | 1993-09-27 | 1996-07-16 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
| US5789542A (en) | 1994-04-22 | 1998-08-04 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Amphipathic peptides |
| US5534499A (en) | 1994-05-19 | 1996-07-09 | The University Of British Columbia | Lipophilic drug derivatives for use in liposomes |
| US5820873A (en) | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| US5885613A (en) | 1994-09-30 | 1999-03-23 | The University Of British Columbia | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes |
| JP4036472B2 (ja) | 1995-04-14 | 2008-01-23 | 一則 片岡 | 片末端に糖、他末端に異なる官能基を有するポリエチレンオキシド及びその製造方法 |
| KR19990007861A (ko) | 1995-04-19 | 1999-01-25 | 가타오카가즈노리 | 헤테로테레케릭 블록 공중합체 및 이의 제조방법 |
| WO1997006202A1 (en) | 1995-08-10 | 1997-02-20 | Kazunori Kataoka | Block polymer having functional groups at both ends |
| US5897945A (en) | 1996-02-26 | 1999-04-27 | President And Fellows Of Harvard College | Metal oxide nanorods |
| US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| US6576239B1 (en) | 1996-09-10 | 2003-06-10 | The Burnham Institute | Angiogenic homing molecules and conjugates derived therefrom |
| GB9708265D0 (en) | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
| KR20000076363A (ko) | 1997-03-18 | 2000-12-26 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | Dna 라이브러리를 제조하기 위한 시험관내 방법 |
| US6180084B1 (en) | 1998-08-25 | 2001-01-30 | The Burnham Institute | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same |
| US6320017B1 (en) | 1997-12-23 | 2001-11-20 | Inex Pharmaceuticals Corp. | Polyamide oligomers |
| NZ508669A (en) | 1998-06-11 | 2003-06-30 | Dimensional Pharm Inc | Pyrazinone protease inhibitors |
| EP1150701A4 (en) * | 1999-01-22 | 2003-03-26 | Burnham Inst | TARGETING PRO-APOPTOTIC CONJUGATES AND METHODS FOR USE THEREOF |
| US6530944B2 (en) | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| ATE346074T1 (de) | 2000-11-30 | 2006-12-15 | Penn State Res Found | Dna methyl transferase inhibitoren |
| US7192921B2 (en) | 2001-11-08 | 2007-03-20 | The Burnham Institute | Peptides that home to tumor lymphatic vasculature and methods of using same |
| ATE419861T1 (de) * | 2001-11-08 | 2009-01-15 | Burnham Inst | Peptide mit homing für lymphgefässtumor und ihre verwendung |
| WO2003087124A2 (en) * | 2002-04-05 | 2003-10-23 | The Burnham Institute | Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells |
| US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| DK1585548T3 (en) | 2002-12-09 | 2018-09-03 | Abraxis Bioscience Llc | COMPOSITIONS AND PROCEDURES FOR THE DELIVERY OF PHARMACOLOGICAL AGENTS |
| US7723474B2 (en) * | 2003-10-21 | 2010-05-25 | The Regents Of The University Of California | Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies |
| CN103169729A (zh) * | 2005-02-18 | 2013-06-26 | 阿布拉科斯生物科学有限公司 | 治疗剂的组合和给予方式以及联合治疗 |
| WO2007090194A2 (en) | 2006-02-01 | 2007-08-09 | The Burnham Institute For Medical Research | Lymphatic zip codes in tumors and pre-malignant lesions |
| WO2008100328A2 (en) | 2006-07-13 | 2008-08-21 | Burnham Institute For Medical Research | METHODS AND COMPOSITIONS FOR TARGETING gC1qR/p32 |
| US8188220B2 (en) | 2006-12-06 | 2012-05-29 | Sanford-Burnham Medical Research Institute | Methods and compositions related to targeting wounds, regenerating tissue, and tumors |
| JP2010514839A (ja) | 2007-01-03 | 2010-05-06 | バーナム インスティテュート フォー メディカル リサーチ | クロット結合化合物に関連する方法および組成物 |
| US8367621B2 (en) | 2008-01-18 | 2013-02-05 | Sanford-Burnham Medical Research Institute | Methods and compositions related to internalizing RGD peptides |
| ES2951646T3 (es) * | 2008-02-21 | 2023-10-24 | Burnham Institute For Medical Res | Métodos y composiciones relacionados con péptidos y proteínas con elementos C-terminales |
| US20100254914A1 (en) * | 2009-02-25 | 2010-10-07 | The Regents Of The University Of California | Nanoworms for in vivo tumor targeting |
| CN102869384B (zh) | 2009-06-22 | 2016-01-13 | 伯纳姆医学研究所 | 使用带有c-端元件的肽和蛋白质的方法和组合物 |
-
2011
- 2011-04-08 JP JP2013503991A patent/JP2013525285A/ja active Pending
- 2011-04-08 EP EP11722941A patent/EP2555802A1/en not_active Withdrawn
- 2011-04-08 US US13/083,176 patent/US20110262347A1/en not_active Abandoned
- 2011-04-08 WO PCT/US2011/031785 patent/WO2011127405A1/en not_active Ceased
- 2011-04-08 CA CA2795289A patent/CA2795289A1/en not_active Abandoned
-
2016
- 2016-12-12 US US15/376,321 patent/US20170246236A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ghosh et al. | Peptides as drug delivery vehicles across biological barriers | |
| Raucher | Tumor targeting peptides: novel therapeutic strategies in glioblastoma | |
| Tripathi et al. | Cell penetrating peptides in preclinical and clinical cancer diagnosis and therapy | |
| Georgieva et al. | Peptide-mediated blood-brain barrier transport of polymersomes | |
| Shin et al. | Cell‐penetrating peptides: Achievements and challenges in application for cancer treatment | |
| Wei et al. | Retro-inverso isomer of Angiopep-2: a stable d-peptide ligand inspires brain-targeted drug delivery | |
| Guidotti et al. | Cell-penetrating peptides: from basic research to clinics | |
| Hervé et al. | CNS delivery via adsorptive transcytosis | |
| Patel et al. | Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives | |
| Timur et al. | The role of peptide-based therapeutics in oncotherapy | |
| Mousavizadeh et al. | Cell targeting peptides as smart ligands for targeting of therapeutic or diagnostic agents: a systematic review | |
| Nakase et al. | Accumulation of arginine-rich cell-penetrating peptides in tumors and the potential for anticancer drug delivery in vivo | |
| US9775803B2 (en) | Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof | |
| Lalatsa et al. | Strategies to deliver peptide drugs to the brain | |
| Gao et al. | Cell-penetrating peptide-based intelligent liposomal systems for enhanced drug delivery | |
| Jafari et al. | Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery | |
| Agrawal et al. | Tailored polymer–lipid hybrid nanoparticles for the delivery of drug conjugate: Dual strategy for brain targeting | |
| Berger et al. | Optimizing pDNA lipo-polyplexes: a balancing act between stability and cargo release | |
| Soudy et al. | Engineered peptides for applications in cancer-targeted drug delivery and tumor detection | |
| Liu et al. | The improved blood–brain barrier permeability of endomorphin-1 using the cell-penetrating peptide synB3 with three different linkages | |
| Raha et al. | Peptide‐mediated cancer targeting of nanoconjugates | |
| Wang et al. | Functionalization of alkyne-terminated thermally hydrocarbonized porous silicon nanoparticles with targeting peptides and antifouling polymers: effect on the human plasma protein adsorption | |
| Buddhiraju et al. | Advances in peptide-decorated targeted drug delivery: exploring therapeutic potential and nanocarrier strategies | |
| JP7072508B2 (ja) | 変異型p53と関連している疾患、障害または病状の処置におけるペプチドおよびその使用 | |
| Asrorov et al. | Cell penetrating peptides: highlighting points in cancer therapy |